CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure.
Clinical trial NCT04109690 · WITHDRAWN
Trial details
- NCT number
- NCT04109690
- Sponsor
- Yale University
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2021-07-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.